Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Vita Life Sciences Limited ( (AU:VLS) ) has provided an update.
Vita Life Sciences has reported a change in the shareholding of director Andrew O’Keefe following transactions under the company’s Long Term Incentive Plan. On 30 April 2026, O’Keefe disposed of 272,483 LTIP shares back to the company at $2.5323 per share and converted 27,517 unquoted LTIP shares into quoted ordinary shares, leaving him with 617,517 shares in total.
The move reflects routine incentive-plan activity rather than a market trade, with all shares sold under the LTIP terms and no changes disclosed in any related contracts. Vita Life Sciences confirmed the transactions did not occur during a closed period requiring prior clearance, signalling standard governance compliance and providing investors with updated visibility on director equity exposure.
More about Vita Life Sciences Limited
Vita Life Sciences Limited is an Australia-listed health and wellness company focused on developing, manufacturing, and marketing nutraceutical and pharmaceutical products. The group operates across the Asia-Pacific region, supplying vitamins, supplements, and related healthcare solutions to retail and professional channels.
Average Trading Volume: 19,710
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$140.2M
Learn more about VLS stock on TipRanks’ Stock Analysis page.